Elagolix sodium

CAS No. 832720-36-2

Elagolix sodium( NBI-56418 sodium )

Catalog No. M20990 CAS No. 832720-36-2

Elagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 65 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 69 In Stock
25MG 140 In Stock
50MG 222 In Stock
100MG 352 In Stock
200MG 520 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Elagolix sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Elagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM respectively).
  • Description
    Elagolix sodium is a GnRH receptor (GnRHR) antagonist ( IC50 and Ki of 0.25 and 3.7 nM respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NBI-56418 sodium
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GNRHR
  • Research Area
    Cancer
  • Indication
    Uterine leiomyoma

Chemical Information

  • CAS Number
    832720-36-2
  • Formula Weight
    653.57
  • Molecular Formula
    C32H29F5N3NaO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (76.50 mM); H2O:50 mg/mL (76.50 mM)
  • SMILES
    COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(CC(NCCCC(=O)[O-])c3ccccc3)c2=O)c1F.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Barra F Scala C Ferrero S2.Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.Drugs Today (Barc). 2019 Apr;55(4):237-246.
molnova catalog
related products
  • C 101248

    C 101248 is a selective and potent inhibitor targeting both mouse and human tandem pore domain halothane-inhibited K+ channel 1 (THIK-1, IC50= 50 nM), without affecting the K2P family members (TREK-1, TWIK-2) and Kv2.1.

  • Carboxyatractyloside

    Carboxyatractyloside dipotassium is a toxic natural product, acts as an inhibitor of ADP/ATP carrier, inhibits mitochondrial ADP/ATP transport.

  • YX-2-107

    YX-2-107 is a selective and potent CDK6-degrading PROTAC with an IC50 value of 4.4 nM.YX-2-107 inhibits RB phosphorylation and FOXM1 expression in vitro, and inhibits the development of Ph+ ALL in rats.